教育中心 >> 预读材料
-
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"JOURNAL：Can J Cardiol.
-
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection FractionJOURNAL：JACC: Heart Failure
-
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectoriesJOURNAL：Eur Heart J.
-
Patient selection and percutaneous technique of unprotected left main revascularizationJOURNAL：Catheter Cardiovasc Interv.
-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionJOURNAL：National Institue for Health and Care Excellence
-
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk FactorsJOURNAL：JACC: Cardiovascular Imaging
-
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart FailureJOURNAL：JACC: Heart Failure
-
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)JOURNAL：Am J Cardiol.
-
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced TrialJOURNAL：Circulation.
-
Ejection Fraction Pros and Cons: JACC State-of-the-Art ReviewJOURNAL：J Am Coll Cardiol.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
